All lobbying filings

ARENTFOX SCHIFF LLP

Lobbying for PINNACLE BIOLOGICS, INC. · Developer of complex critical care therapies for cancers

Filing · LD-1 registration Registration

Reporting period

3rd Quarter 2025

July 1 - Sep 30 · Posted Oct 1, 2025

Money reported

None

Registrations and no-activity reports carry no figure.

Client based in

Illinois

Official filing document

Lobbyists on this filing 2

DAN RENBERG New on this filing

Previously held: Member, Board of Directors, Ex-Im Bank (1999-2003); Leg. Director and Dep. Chief of Staff, Sen. Arlen Specter (1994-1998)
BLAKE THELANDER New on this filing

Previously held: Health Policy Advisor/Legislative Director, Rep. Mariannette Miller-Meeks (2023-2025), Staff Assistant/Legislative Assistant/Senior Legislative Assistant, Rep. Jefferson Van Drew (2020-2023), Intern, Rep. Ralph Norman (2019-2019)

A "covered position" is a government job the lobbyist held in the 20 years before registering, which the law requires them to name. See the revolving door for former members of Congress across all filings.

Lobbying activity 1

Medicare/Medicaid

Calendar Year 2026 Hospital Outpatient Prospective Payment System proposed rule regarding Medicare coverage for a Pinnacle biologic product

Foreign interests disclosed 4

Section 7 of the LD-2: foreign entities that own part of the client, paid toward this lobbying, or stand to benefit from it.

ADVANZ PHARMA CORP. LIMITED

Jersey · St. Helier · owns 100% of the client · contributed $0
ADVANZ PHARMA HOLDCO LIMITED

Jersey · St. Helier · owns 100% of the client · contributed $0
CIDRON AIDA LIMITED

Jersey · St. Helier · owns 98.88% of the client · contributed $0
NORDIC CAPITAL LIMITED (PER FUND X)

Jersey · St. Helier · owns 98.88% of the client · contributed $0

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.